Climb Bio, Inc.

Item 2.02 Results of Operations and Financial Condition. On August 6, 2026, Climb Bio, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, whether filed before or after the date hereof and regardless of any general incorporation language in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits .

Press release of Climb Bio, Inc., dated August 6, 2026

Cover Page Interactive Data File (embedded within the Inline XBRL document)